BELLEVUE GROUP AG Bio-Rad Laboratories, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$42.47M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

-15.73%
quarter

Bio-Rad Laboratories, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +11.69% 10.65K shares -2.65M $417.14 101.81K
Q2 2022 share Increase +26.60% 19.15K shares 4.56M $495 91.16K
Q1 2022 share Increase +81.46% 32.32K shares 10.57M $563.23 72.00K
Q4 2021 share Decrease -13.76% -6.33K shares -4.34M $758.65 39.68K
Q3 2021 share Decrease -47.29% -41.28K shares -21.92M $745.95 46.01K
Q2 2021 share Decrease -12.87% -12.90K shares -985K $644.29 87.30K
Q1 2021 share Increase +55.58% 35.79K shares 19.68M $571.17 100.20K
Q4 2020 share Decrease -17.63% -13.78K shares -2.75M $582.94 64.40K
Q3 2020 share Decrease -2.11% -1.68K shares 4.24M $515.46 78.18K
Q2 2020 share Increase +28.05% 17.49K shares 14.19M $451.49 79.87K
Q1 2020 share Increase +33.32% 15.58K shares 4.55M $350.56 62.37K
Q4 2019 share Increase +593.11% 40.03K shares 15.06M $370.03 46.78K
Q3 2019 share Increase 0.00% 6.75K shares 2.24M $332.74 6.75K